Global Health Innovative Technology (GHIT) Fund
Non-profit OrganizationsView the employees at
Global Health Innovative Technology (GHIT) Fund-
Anna-Karin Tidén Research Officer at Stockholm University
-
Greater Stockholm Metropolitan Area
-
Rising Star
Mina Ohata Senior Manager, Brand Communications-
Tokyo, Tokyo, Japan
-
Rising Star
Kiichiro Kobori Investment Strategy, Portfolio Development & Innovations-
Tokyo, Japan
-
Top 5%
Isaac Chikwanha Senior Director at Global Health Innovative Technology (GHIT) Fund-
Rising Star
Overview
The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, and international philanthropic foundations.
-